Objectives: A burn unit of a hospital in Tunis underwent an endemic situation caused by imipenem-resistant Pseudomonas aeruginosa. For nine non-repetitive isolates of a clonal VIM-2-producing strain, the bla VIM-2 genetic background was characterized and the associated qnrVC1 gene molecularly analysed.
Introduction
Pseudomonas aeruginosa is a saprophytic organism that is widespread in moist environments and has become a major nosocomial pathogen in patients with impaired defence systems, such as burn patients. 1 Currently, carbapenems are the first-line treatment for MDR P. aeruginosa infections. However, carbapenem resistance is increasing dramatically worldwide. The most reported mechanisms are the loss of the OprD porin, and more recently, the production of carbapenemases, especially the socalled metallo-b-lactamases (MBLs). 2 MBLs are mainly encoded by mobile gene cassettes inserted into integrons that often harbour other resistance determinants.
In this study, several clonal strains of imipenem-resistant P. aeruginosa were collected in a burn unit of a Tunisian hospital. 3 One of them carried an uncommon integron encompassing bla VIM-2 , associated with qnrVC1 and genes encoding a bacterial group II intron. The expression of qnrVC1 and the subsequent conferred resistance were investigated.
Materials and methods

Bacterial strains
Between November 2007 and August 2008, nine non-repetitive imipenem-resistant isolates of P. aeruginosa belonging to a clonal strain were collected in the Burn Centre of the Aziza Othmana Hospital in Tunis. Identification to species level was confirmed by the API 20NE system (bioMé rieux, Marcy-l'É toile, France). An azide-resistant mutant of Escherichia coli C600, E. coli TOP10 and P. aeruginosa ATCC 27853 were 
Antibiotic susceptibility testing
Susceptibility to 23 antimicrobial agents was determined for the nine clinical strains by the disc diffusion method (http://www.sfmmicrobiologie.org). The presence of MBLs was investigated by imipenem discs either supplemented or not with EDTA (750 mg). Imipenem MICs were determined alone and in combination with a fixed concentration of EDTA (320 mg/L) by the agar dilution method (http://www.sfmmicrobiologie.org). Quinolone MICs were determined using Etest strips according to the manufacturer's recommendations (bioMérieux).
Plasmid content analysis and conjugation and transformation experiments
Imipenem resistance transfer to an azide-resistant mutant of E. coli was attempted by a filter-mating technique. Putative transconjugants were selected on agar plates containing ampicillin (100 mg/L) and sodium azide (300 mg/L). Plasmid DNA was extracted using an alkaline-lysis method. 4 Putative plasmid DNA extract obtained from the representative clinical isolate Pa25 was electroporated into E. coli TOP10 and P. aeruginosa ATCC 27853 with selection on agar plates containing ampicillin (100 mg/L) or ticarcillin (100 mg/L).
PCR experiments and DNA sequencing
Total DNA was extracted from the P. aeruginosa strains as previously described. 4 The detection of carbapenemase genes (bla VIM , bla IMP , bla KPC and bla NDM-1 ) and plasmid-mediated quinolone resistance determinants [qnrA, qnrB, qnrS, qepA and aac(6 ′ )-Ib-cr] and the characterization of the integron structure were performed by PCR in the nine clonally related strains under standard conditions 4 using published 4 -8 or laboratorydesigned primers. Mutations in the quinolone resistance-determining regions of the gyrA, gyrB, parC and parE genes were characterized by sequencing after PCR using published primers. 9 For sequencing, PCR products purified with the Gene JET PCR Purification kit (Fermentas, Villebon sur Yvette, France) and plasmids were used as templates in a cycle reaction using the AmpliTaq DNA polymerase FS Dye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems Division, PerkinElmer) and an automatic ABI 3130xl sequencer (Applied Biosystems Division, PerkinElmer). Sequences were analysed using the 'BioEdit' software and the NCBI web site (http://www.ncbi.nlm.nih.gov).
Cloning experiments
qnrVC1 expression was explored by cloning the qnrVC1 gene cassette using PCR products from the Pa25 strain and the pGEMT easy kit (Promega, Charbonniè res, France) or the Pseudomonas/E. coli shuttle vector pCN60 (ATCC 77101). The DNA fragment amplified included the qnrVC1 promoter region (primers arr6-F 5 ′ -ATGTCGAGTGACTGGACTCC-3 ′ and aaddi 5 ′ -CAGGAACCGGATCAAAGAGT-3 ′ for cloning into pGEMT, and qnrVF-Pst 5 ′ -CACACACTGCAGATGTCGAGTGACTGGACTCC-3 ′ and qnrVR-Hind 5 ′ -CAC ACAAAGCTTCAGGAACCGGATCAAAGAGT-3 ′ for cloning into pCN60, both restricted by HindIII and PstI). The recombinant plasmids were transformed by electroporation either into E. coli TOP10 and selected on ampicillin (100 mg/L) agar plates or into P. aeruginosa ATCC 27853 and selected on ticarcillin (100 mg/L) agar plates.
Molecular typing
For the nine VIM-2-producing isolates, PFGE analysis was performed according to the manufacturer's instructions (Bio-Rad, Marnes la Coquette, France) using whole-cell DNA digested with SpeI restriction enzyme.
Nucleotide sequence accession number
The nucleotide sequence reported here is available in GenBank (accession number JX861889).
Results and discussion
Origin of the P. aeruginosa strains Nine non-repetitive isolates collected from eight patients and one environmental sample (tap water) were demonstrated to be clonally related by PFGE (data not shown). These isolates, responsible for a limited outbreak from November 2007 to January 2008, were recovered from blood cultures (n ¼ 4), cutaneous wounds (n ¼ 3) and an invasive device (n ¼ 1). They exhibited high-level imipenem resistance (mode MIC .128 mg/L, range MIC 128 to .128 mg/L), and addition of EDTA restored the imipenem activity at least in part (mode MIC¼ 32 mg/L, range MIC 8 -64 mg/L), suggesting the presence of an MBL. PCR amplification and sequencing revealed the presence of bla VIM-2 . No other carbapenemase was detected in these strains. MBL-producing P. aeruginosa have been described worldwide, and VIM-2 is the most prevalent MBL, reported from all continents, 10 particularly in southern European countries such as Italy, Greece and France. 11 Recent studies have reported the dissemination of VIM-2 P. aeruginosa in Tunisia, mainly due to the spread of clonal strains. 12 -14 bla VIM-2 genetic support and environment Despite repeated attempts, imipenem resistance transfer to an azide-resistant mutant of E. coli yielded no transconjugants (,10 28 ). Plasmid analysis of Pa25 failed to detect a plasmid, and transformation by electroporation of putative plasmid DNA extract into E. coli TOP10 or P. aeruginosa ATCC 27853 was unsuccessful, suggesting a chromosomal location of the gene.
In the nine clinical isolates, characterization of the bla VIM-2 flanking regions showed that this gene was located on the same large and original integron of 7500 bp (Figure 1 ). It was found to contain bla VIM-2 and bla OXA-2 (b-lactam resistance), two copies of aadB (gentamicin and tobramycin resistance), arr-6 (rifampicin resistance) and aadA1a (streptomycin and spectinomycin resistance). In addition, this integron contains a qnrVC1 gene cassette encoding quinolone resistance that has been previously reported in a class 1 integron of a clinical Brazilian Vibrio cholerae strain. 15 The qnrVC1 determinant showed higher homology with the chromosomally encoded qnr genes of Vibrionaceae, especially Photobacterium profundum, than with the plasmidmediated qnr genes of Enterobacteriaceae. 16 In our strains, the qnrVC1 gene cassette was composed of an attC site that is similar to the Vibrio parahaemolyticus repeat site and is characteristic of superintegrons. Moreover, this attC exhibits the core site GTTATGT and the inverse core site ACATAAC. Moreover, the gene cassette contains a 5 ′ -untranscribed region including a functional promoter. 17 This is the first known description of qnrVC in P. aeruginosa located in a new integron. In addition, this integron possesses genes encoding a bacterial group II intron. This intron belongs to the group IIC-attC introns, and the feature of this group is to be inserted in the inverse core site of the attC Belotti et al.
recombination site of the aadA1 gene cassette (Figure 1 ) in the opposite orientation from the gene cassette. In this study, the sequence shows 78% homology with the most closely related sequence found in an integron from a South Korean strain of P. aeruginosa (GenBank number JF429900). Recently, a potential role for group IIC-attC introns in gene cassette formation has been suggested, 18, 19 and its presence in our integron likely represents this role.
Expression of the qnrVC1 determinant
As for some rare gene cassettes, the one described here encompassing qnrVC1 possesses a promoter. In the one previously described gene cassette that is similar, this promoter seemed functional by 5 ′ RACE. 17 To explore the expression of qnrVC1 and its role in quinolone resistance, the gene with its promoter were cloned into E. coli and into P. aeruginosa. Various transformants containing recombinant plasmids constructed using pGEMT in E. coli and pCN60 in E. coli and P. aeruginosa were obtained. By sequencing, the recombinant plasmids were chosen to be unaffected by the pGEMT plac promoter. Quinolone MIC determination showed that the qnrVC1 gene with its own promoter conferred decreased susceptibility to fluoroquinolones, especially ciprofloxacin, in E. coli (MIC 0.125 versus 0.006 mg/L for the recipient strain; Table 1 ). QnrVC1 protein affected nalidixic acid only slightly, in contrast to most plasmid-mediated Qnr in Enterobacteriaceae. 16 However, the level of decreased susceptibility to fluoroquinolones was close to that observed with the other qnr genes, i.e. a 42-fold increase in the ciprofloxacin MIC. 20 In contrast, qnrVC1 seemed to have no effect in P. aeruginosa, possibly due to the inefficiency of the promoter or the protein in this species. However, in the clinical strain Pa25, fluoroquinolone MICs were very high (ciprofloxacin MIC .32 mg/L) and quinolone resistance-determining region sequencing revealed two common substitutions, Ile for Thr-83 in GyrA and Leu for Ser-87 in ParC, that explain the high-level quinolone resistance in this strain. 9 No other plasmid-mediated quinolone resistance was detected in the clinical strain.
Conclusions
In conclusion, this burn unit underwent a prolonged outbreak of VIM-2-producing P. aeruginosa belonging to different clones. Analysis of these epidemic strains led us to characterize an original integron containing the qnrVC1 cassette and a new group IIC-attC intron. This study emphasizes the strategic role of integrons in the emergence of new resistance determinants, which may be linked to group IIC-attC intron presence, and the role of The sequences above correspond to the recombination site in the beginning of the qnrVC1 gene cassette and to the attC site, respectively. The core site and the inverse core site are underlined, the qnrVC1 promoter is in bold and the start codon (ATG) of qnrVC1 is indicated in italics. The sequence below represents the integration site of the group II intron in the attC site of the aadA1 gene cassette. The stop codon (TAA) of aadA1 is indicated in italics, and the inverse core site of aadA1 is underlined. bla VIM-2 , qnrVC1 integron 2239 JAC P. aeruginosa in the dissemination of these determinants from environmental strains to clinical ones. This is the first known description of a qnrVC or even a qnr gene in P. aeruginosa from where these resistant genes could be transferred to enterobacterial species. We showed that QnrVC1 confers low-level fluoroquinolone resistance to E. coli, and Qnr proteins are known to facilitate the emergence of high-level quinolone-resistant mutants by raising the level at which they can be selected. 20 
